128 related articles for article (PubMed ID: 4062612)
1. High-dose intravenous methylprednisolone in myasthenia gravis.
Arsura E; Brunner NG; Namba T; Grob D
Arch Neurol; 1985 Dec; 42(12):1149-53. PubMed ID: 4062612
[TBL] [Abstract][Full Text] [Related]
2. [Results of myasthenia treatment with methylprednisolone pulses. Preliminary study].
Owczarek E; Emeryk-Szajewska B; Strugalska-Cynowska M
Neurol Neurochir Pol; 1995; 29(5):651-61; quiz 662. PubMed ID: 8584092
[TBL] [Abstract][Full Text] [Related]
3. Corticotropin and corticosteroids in generalized myasthenia gravis: comparative studies and role in management.
Brunner NG; Berger CL; Namba T; Grob D
Ann N Y Acad Sci; 1976; 274():577-95. PubMed ID: 183590
[TBL] [Abstract][Full Text] [Related]
4. Extraocular muscle responses to high dose intravenous methylprednisolone in myasthenia gravis.
Komiyama A; Arai H; Kijima M; Hirayama K
J Neurol Neurosurg Psychiatry; 2000 Feb; 68(2):214-7. PubMed ID: 10644791
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of high-dose intravenous methylprednisolone therapy for ocular myasthenia gravis.
Ozawa Y; Uzawa A; Kanai T; Oda F; Yasuda M; Kawaguchi N; Himuro K; Kuwabara S
J Neurol Sci; 2019 Jul; 402():12-15. PubMed ID: 31100651
[TBL] [Abstract][Full Text] [Related]
6. High-dose intravenous immunoglobulin in the management of myasthenia gravis.
Arsura EL; Bick A; Brunner NG; Namba T; Grob D
Arch Intern Med; 1986 Jul; 146(7):1365-8. PubMed ID: 3718134
[TBL] [Abstract][Full Text] [Related]
7. [Randomized controlled clinical trial of middle-dose cyclophosphamide plus methylprednisolone for myasthenia gravis patients in crisis].
Feng HY; Liu WB; Qiu L; Huang X; Luo CM; Li Y; Wang HY
Zhonghua Yi Xue Za Zhi; 2012 Sep; 92(35):2473-6. PubMed ID: 23158712
[TBL] [Abstract][Full Text] [Related]
8. Corticosteroids in management of severe, generalized myasthenia gravis. Effectiveness and comparison with corticotropin therapy.
Brunner NG; Namba T; Grob D
Neurology; 1972 Jun; 22(6):603-10. PubMed ID: 4343255
[No Abstract] [Full Text] [Related]
9. Long-term prednisone followed by thymectomy in myasthenia gravis.
Mann JD; Johns TR; Campa JF; Muller WH
Ann N Y Acad Sci; 1976; 274():608-22. PubMed ID: 1066998
[TBL] [Abstract][Full Text] [Related]
10. Effects of repeated doses of intravenous immunoglobulin in myasthenia gravis.
Arsura EL; Bick A; Brunner NG; Grob D
Am J Med Sci; 1988 May; 295(5):438-43. PubMed ID: 3376987
[TBL] [Abstract][Full Text] [Related]
11. High-dose steroids for perioperative management of patients with myasthenia gravis undergoing thymectomy. A preliminary report.
Bolooki H; Schwartzman RJ
J Thorac Cardiovasc Surg; 1978 May; 75(5):754-7. PubMed ID: 642573
[TBL] [Abstract][Full Text] [Related]
12. Rationale for the clinical guidelines for myasthenia gravis in Japan.
Murai H; Utsugisawa K; Nagane Y; Suzuki S; Imai T; Motomura M
Ann N Y Acad Sci; 2018 Feb; 1413(1):35-40. PubMed ID: 29377151
[TBL] [Abstract][Full Text] [Related]
13. [Intermittent methylprednisolone pulse therapy for myasthenia gravis in childhood].
Tanaka J; Matsuzaki K; Arai H; Nagai T; Matsumoto Y; Okada S
No To Hattatsu; 1994 Jan; 26(1):14-9. PubMed ID: 8280441
[TBL] [Abstract][Full Text] [Related]
14. Comparative effectiveness and safety of intravenous methylprednisolone and tacrolimus monotherapy in ocular myasthenia gravis with unsatisfactory prednisone responses: a retrospective study.
Zhang KY; Duan WW; Luo YB; Li Y; Hu J; Yang H
Orphanet J Rare Dis; 2024 Jan; 19(1):19. PubMed ID: 38243274
[TBL] [Abstract][Full Text] [Related]
15. Treatment of myasthenia gravis with methylprednisolone pulse: a double blind study.
Lindberg C; Andersen O; Lefvert AK
Acta Neurol Scand; 1998 Jun; 97(6):370-3. PubMed ID: 9669469
[TBL] [Abstract][Full Text] [Related]
16. [Hallucinations after infusion of large doses of corticosteroids. A well-known and unusually well-reported side effect].
Askmark H
Lakartidningen; 1999 Mar; 96(11):1336. PubMed ID: 10194916
[No Abstract] [Full Text] [Related]
17. [Myasthenia gravis: life-saving effect of a massive dose of intravenous methylprednisolone].
Szobor A; Bárdosi Z; Klátyik M; Klein M
Orv Hetil; 1988 Mar; 129(10):495-6, 499. PubMed ID: 3362539
[No Abstract] [Full Text] [Related]
18. Intravenous methylprednisolone pulse therapy in minimal change nephrotic syndrome.
Yeung CK; Wong KL; Ng WL
Aust N Z J Med; 1983 Aug; 13(4):349-51. PubMed ID: 6580858
[TBL] [Abstract][Full Text] [Related]
19. High-dose intravenous methylprednisolone in the treatment of multiple sclerosis: clinical-immunologic correlations.
Durelli L; Cocito D; Riccio A; Barile C; Bergamasco B; Baggio GF; Perla F; Delsedime M; Gusmaroli G; Bergamini L
Neurology; 1986 Feb; 36(2):238-43. PubMed ID: 3511404
[TBL] [Abstract][Full Text] [Related]
20. Beneficial effects of corticosteroids on ocular myasthenia gravis.
Kupersmith MJ; Moster M; Bhuiyan S; Warren F; Weinberg H
Arch Neurol; 1996 Aug; 53(8):802-4. PubMed ID: 8759987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
